&w=3840&q=100)
AstraZeneca Pharma rises 2% on securing CDSCO nod for Benralizumab solution
At 1:30 PM, AstraZeneca Pharma shares were trading 1.26 per cent higher at ₹8,018.90 per share. By comparison, the BSE Sensex was trading 0.21 per cent lower at 81,461.57 levels.
Why did AstraZeneca share price rise in trade today?
AstraZeneca Pharma share price rose after it received approval from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India, to import for sale and distribution of Benralizumab 30 mg/ml solution for injection (brand name: Fasenra) for an additional indication.
In an exchange filing, AstraZeneca Pharma said, 'This is to inform that AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India to import for sale and distribution of Benralizumab 30 mg/ml Solution for Injection (Brand name: Fasenra) for an additional indication.'
Benralizumab is used as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA).
Besides, the approval also paves way for the marketing of Benralizumab 30 mg/ml solution for injection (Brand name: Fasenra) in India for the specified additional indication, subject to the receipt of related statutory approvals, if any.
Earlier this week, AstraZeneca Pharma India secured approval from CDSCO to import for sale and distribution of Osimertinib Tablets 40 mg & 80 mg (TAGRISSO) for an additional indication.
Osimertinib as monotherapy is used in the treatment of patients with locally advanced, unresectable (stage III) NSCLC whose tumours have EGFR exon 19 deletions or exon 21 (L858R) substitution mutations, and whose disease has not progressed during or following platinum-based chemoradiation therapy
AstraZeneca Pharma Q4 results
The Board of Directors of AstraZeneca Pharma will meet today to consider and approve the March quarter of financial year 2025 (Q4FY25) and financial year 2025 (FY25) results, along with dividend for FY25, if any.
About AstraZeneca Pharma
AstraZeneca Pharma is a British-Swedish multinational pharmaceutical and biotechnology company, formed in 1999 through the merger of Sweden's Astra AB and Britain's Zeneca Group.
The company is dedicated to developing and selling innovative medicines across various therapeutic areas, including cancer, cardiovascular diseases, gastrointestinal issues, infections, neuroscience, respiratory conditions, and inflammation.
The company has had a major presence in India for 45 years. AstraZeneca Pharma India oversees manufacturing, sales, and marketing operations, while the company also gained global recognition for its role in developing the Oxford–AstraZeneca Covid-19 vaccine
Leveraging data science and artificial intelligence (AI), AstraZeneca claims to boost the success rates and efficiency of its research and development (R&D) processes.
The market capitalisation of AstraZeneca Pharma is ₹20,037.38 crore, according to BSE. The company falls under the BSE500 index. The 52-week high of AstraZeneca share price is ₹9,199, while its 52-week low is ₹5,415.55.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
25 minutes ago
- Hans India
Nifty, Sensex open flat; IT, pharma stocks rally
Mumbai: The Indian benchmark indices opened flat on Thursday, as IT and pharma stocks showed considerable gains. The BSE Sensex advanced 0.15 per cent to 80,657 points. The Nifty 50 inched up to 24,638, up 21 points or 0.08 per cent. Among the broader market indices BSE SmallCap added 0.12 per cent and the BSE MidCap climbed 0.30 per cent. Sectorally, Nifty Metal lost 1.05 per cent while Nifty IT and Nifty Pharma surged 0.76 per cent and 0.93 per cent, respectively. The majority of other indices were mixed. In the Nifty pack, Infosys led the gainers, surging 1.29 per cent, followed by HDFC Life, Wipro, Adani Ports, and Apollo Hospitals. Among laggards, Tata Steel declined 1.22 per cent, followed by ONGC, Kotak Mahindra Bank and Hindalco. The market will be in a wait-and-watch mode looking for clues from the Donald Trump-Vladimir Putin summit and Prime Minister Narendra Modi's Independence Day message, said analysts. From the technical perspective, the market is oversold, and short-positions are high. Any positive news that triggers short covering can lead to a rally, said Dr. VK Vijayakumar, Chief Investment Strategist, Geojit Investments Ltd. "On the downside, immediate support for Nifty is placed at 24,500, followed by the 24,400–24,300 zone. As long as the index manages to hold above these support levels, extended selling pressure is unlikely. On the upside, 24,700 will act as the immediate resistance," added Hardik Matalia from Choice Broking. India's inflation rate based on CPI eased further to 1.55 per cent in July this year amid a decline in food prices. This is the lowest level of year-on-year retail inflation since June 2017. Despite uncertainties around Trump's trade stance and global risks, India's growth-inflation dynamics remain favourable for FY26, with a marginal downgrade based on tariff updates. Asia-Pacific markets traded mixed as investors bet on a rate cut by the US Federal Reserve next month. US markets ended higher overnight, as the Dow Jones rose 1.04 per cent, the S&P 500 gained 0.32 per cent, and the Nasdaq Composite edged up 0.14 per cent. Asian markets traded mixed. Japan's Nikkei fell 1.36 per cent after hitting fresh highs yesterday. The Shanghai Composite added 0.2 per cent, while the Shenzhen Component eased 0.15 per cent. Hong Kong's Hang Seng dipped 0.09 per cent, and South Korea's Kospi declined 0.28 per cent. On Wednesday, foreign institutional investors (FIIs) extended their selling streak, offloading equities worth Rs 3,644 crore, while domestic institutional investors (DIIs) were net buyers, purchasing equities worth Rs 5,623 crore.
Time of India
37 minutes ago
- Time of India
Stock market today: Nifty50 opens in green; BSE Sensex near 80,600
Analysts anticipate the market to remain range-bound, with domestic-facing themes expected to prevail. (AI image) Stock market today: Nifty50 and BSE Sensex , the Indian equity benchmark indices, opened in green on Thursday. While Nifty50 was above 24,600, BSE Sensex was near 80,600. At 9:33 AM, Nifty50 was trading at 24,619.65, up marginally. BSE Sensex was at 80,589.58, up 50 points or 0.062%. Analysts anticipate the market to remain range-bound, with domestic-facing themes expected to prevail amid caution over US tariffs and the forthcoming US-Russia peace talks scheduled for Friday. Dr. VK Vijayakumar, Chief Investment Strategist, Geojit Investments Limited said, 'The market will be in a wait and watch mode looking for clues from the Trump-Putin summit and PM Modi's Independence Day message. From the technical perspective, the market is oversold and short-positions are high. Any positive news which triggers short covering can lead to a rally. We will have to wait and watch.' 'Fundamentally strong banking stocks have drifted down in the last one month while mid and smallcaps with elevated valuations continue to remain resilient. This a liquidity driven short-term aberration. Long-term investors can exploit this value discrepancy by moving away from highly valued mid and smallcaps to the safety of high quality largecaps." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Your Finger Shape Says a Lot About Your Personality, Read Now Tips and Tricks Undo US equity indices edged higher on Wednesday, extending a global rally driven by expectations of lower interest rates. The S&P 500 gained 0.3% to reach another record high, the Dow Jones surged 463 points (1%), and the Nasdaq inched up 0.1% to a fresh peak. Asian stocks trading within a narrow range at Thursday's open, easing after three days of gains propelled by bets on a Federal Reserve rate cut next month. Oil prices increased on Thursday, recovering after a decline in the previous session. The upcoming meeting between US President Donald Trump and Russian President Vladimir Putin has heightened market risk premiums. Foreign portfolio investors sold shares worth Rs 3,644 crore on Wednesday, while domestic institutional investors were net buyers, purchasing shares worth Rs 5,624 crore. Stay informed with the latest business news, updates on bank holidays , public holidays , current gold rate and silver price .
Hans India
an hour ago
- Hans India
Easing inflation renews buying on bourses
Mumbai: Stock markets rebounded on Wednesday with benchmark Sensex closing higher by 304 points on buying in metal, auto and pharma shares as steady US inflation data propelled a sharp rally in global markets. The 30-share BSE Sensex climbed 304.32 points or 0.38 per cent to settle at 80,539.91. During the day, it jumped 448.15 points or 0.55 per cent to 80,683.74. The 50-share NSE Nifty edged up by 131.95 points or 0.54 per cent to 24,619.35. Analysts said retail inflation slowing to an 8-year low of 1.55 per cent in July led to the positive trend in domestic equities. 'Indian equities experienced a broad-based optimism as CPI hit an eight-year low, boosting hopes for a revival in discretionary spending, led by autos and metals. Globally, sentiment improved on the extension of China's tariff deadline and easing oil prices. 'Despite uncertainties around Trump's trade stance and global risks, India's growth-inflation dynamics remain favourable for FY26 with risk to marginal downgrade based on tariff updates. India looks forward to the Trump-Putin meet dated 15th August,' Vinod Nair, Head of Research, Geojit Investments Limited, said. Among Sensex firms, Bharat Electronics, Eternal, Mahindra & Mahindra, Kotak Mahindra Bank, Tata Motors and Power Grid were the gainers. However, Adani Ports, ITC, UltraTech Cement and Titan were among the laggards.
